Chapter 1: Welcome and introductions
This round table is designed to provide clinicians with a better understanding of the long-term CV risks of LDL-C exposure. In addition to reviewing the pathogenesis of atherosclerosis and assessing the long term implications of elevated LDL-C, this meeting will consider current guidance around controlling LDL-C, the challenges in achieving LDL-C targets, and evaluate how emerging strategies are contributing to LDL-C management.
Each chapter will comprise of a short presentation by the named medical expert followed by a panel discussion amongst all faculty.
- Outline the pathogenic nature and clinical risk of extended exposure to elevated LDL-C
- Describe the clinical challenges in achieving guideline-based LDL-C goals
- Compare and contrast LDL-C lowering therapies